| Authors: |
Trapani D; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA., Jin Q; Data Science, Dana-Farber Cancer Institute, Boston, MA., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Rugo HS; University of California at San Francisco, San Francisco, CA., Reeder-Hayes KE; University of North Carolina, Lineberger Comprehensive Cancer Institute, Chapel Hill, NC., Traina T; Memorial Sloan Kettering Cancer Center, New York, NY., Abdou Y; University of North Carolina, Lineberger Comprehensive Cancer Institute, Chapel Hill, NC., Falkson C; University of Alabama, Birmingham, AL., Abramson V; Vanderbilt University, Nashville, TN., Ligibel J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA., Chen W; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA., Come S; Harvard Medical School, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MA., Nohria A; Harvard Medical School, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA., Ryabin N; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Tayob N; Harvard Medical School, Boston, MA; Data Science, Dana-Farber Cancer Institute, Boston, MA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA., Mayer EL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: erica_mayer@dfci.harvard.edu. |
